T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05316116	Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)	terminated	Early Phase 1	6	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Feb 5, 2026	clinicaltrials
NCT03272633	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies	terminated	Early Phase 1	2	Rutgers, The State University of New JerseyOTHER	1	Jun 26, 2023